For instance, Mitra Ghasemi-Chaleshtari and colleagues employed SPION nanoparticles loaded with siRNAs targeting PD-1 and A2aR, achieving substantial tumor growth inhibition and enhanced anti-tumor immune responses (27). The gene discussed is ADORA2A; the disease is neoplasm.